VeriMomdea-lauraminopropionate est-il sûr pendant la grossesse ?
No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
Related ingredients
Frequently asked questions
- dea-lauraminopropionate est-il sûr pendant la grossesse ?
- No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
- dea-lauraminopropionate est-il sûr pendant l'allaitement ?
- No data indicate DEA‑lauraminopropionate is classified as a reproductive or lactation hazard; breastfeeding risk would be driven by maternal systemic absorption of DEA moiety, for which no human milk transfer data were identified. Theoretical mechanistic concern derives from DEA animal data, but there is no product‑specific evidence showing transfer into breast milk. (Sources: CIR / DEA literature; PubMed animal study.)
- dea-lauraminopropionate est-il sûr pour la peau de bébé ?
- There are no infant‑specific toxicity or classification data for DEA‑lauraminopropionate. Following conservative exposure considerations, measurable dermal absorption in adults (low) is expected to be higher in infants because of immature skin and higher surface‑area‑to‑body‑weight, so exposure score is increased by +1; hazard remains based on absence of direct evidence for this compound and reliance on theoretical concern from the DEA moiety. (Sources: regulatory INCI listings; DEA animal data.)
- Comment VeriMom évalue-t-il dea-lauraminopropionate ?
- VeriMom évalue dea-lauraminopropionate à 87/100 (risque faible) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à dea-lauraminopropionate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à dea-lauraminopropionate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.